Teva fails to invalidate Vigamox

U.S. District Judge Sue L. Robinson (Delaware) ruled last week that Israel’s Teva Pharmaceuticals infringed the patents for Vigamox and failed to prove the patents invalid. Vigamox is used to treat eye infections and is made by Nestle’s Alcon unit. Teva challenged the validity of the patent in 2006. If it had been successful, Teva would have been able to launch its own competing product in 2014, six years before the expiration of the Vigamox patent.

This entry was posted on Monday, October 26th, 2009 at 4:43 pm and is filed under News, Patents, Teva, US, pharmaceuticals. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply